Immupharma Share Discussion Threads

[deanmatlazin] 05/6/2019 17:24

Last time the trial involved on patients already on meds for Lupus such at methotrexate etc.

Lupuzor MAP is designed for early access to lupuzor and of course it will be double blind randomised placebo-controlled study. That is where we can get statistically significant result. It will be better than toxic drug to use such as methotrexate. I am sure they are company out there will fund Lupuzor MAP study and have 50% ownership of Lupuzor. It is still a strong buy at this price.

[njb67] 05/6/2019 17:06

kirk

It is not going to be transformational. They will have some uncontrolled observational data. They also have no money.

Even if Lupuzor looks good in the observational data (big risk here is placebo effect), any suitor is going to low-ball any offer as IMM do not have the resources to take this product forward.

[kirk 6] 05/6/2019 16:55

Have you listened to latest interview and Q and A? Look back through recent posts. Could be transformational

[coldspring] 05/6/2019 16:46

What is driving this though? No logic at all

[kirk 6] 05/6/2019 16:41

At close you could sell 200k through the rsp and only buy 15k. L2 was also deplete of any sells other than usual mms who have to create a price . Should surge into 20s tomorrow

[ny boy] 05/6/2019 16:32

L2 doesn’t lie! Melt up underway as predicted

Great stuff, watch (MSYS) move up rapidly next, all buys today!

[herb clark] 05/6/2019 16:31

Or it could just be the herd following?

[deanmatlazin] 05/6/2019 16:27

News leaking...massive buys at min. Hope we get back to 50p baseline

[kirk 6] 05/6/2019 16:25

Probably plenty of major players already have forms of L2 software

[herb clark] 05/6/2019 15:31

Can anyone sell Level 2?

[ahmedbin69] 05/6/2019 15:05

92p price target Don't make me laughPmsl

[herb clark] 05/6/2019 14:59

Is level 2 still looking good?

[ny boy] 05/6/2019 14:56

A lot of buying on L2, looks good for a big move soon, (MSYS) next, good buying there on a breakout dyor of course.

[ny boy] 05/6/2019 14:40

No but i’m Sure savvy investors are bearing that in mind, watch for a 100%+ melt up day this month

[kirk 6] 05/6/2019 14:00

Not to mention the 92p price target recently issued

[kirk 6] 05/6/2019 14:00

The upside here is astronomical if positive study is shown- re read the latest Q and A

[ny boy] 05/6/2019 13:38

Good buying here, whilst few are on the thread anymore, certainly some secret buying going on, smells of leaky good news if you ask me, over 20p anyone ?

[bjfanc] 05/6/2019 13:21

Is that Tim McCarthy from Alizyme. Famed for taking things onto Phase 3. No matter what Phase 2 showed.

[ny boy] 05/6/2019 12:36

Aye added some sub 10p a while ago, see what happens, steady progress north so far.
Adding (STX) on the mini dips and accumulating (MSYS) which has just started a move through resistance and out of an inverted H & S on the chart!

[supernumerary] 05/6/2019 11:03

How can you show a statistically significant result without a control?

[deanmatlazin] 05/6/2019 10:03

Result is imminent and I am confidence the subgroup 62 patients on extended programme will show statistically significant positive result. This will bring confidence to other company want to collaborate and invest for Lupusor MAP. I think LUPUZOR MAP is the best route to show statistically significant result than placebo. However that will be another 2 years of waiting. On saying that...this is the best time to buy whilst the share price at the bottom.

[miavoce] 05/6/2019 08:29

Seems to be building a good head of steam in advance of the imminent results from the extension study...

[njb67] 03/6/2019 18:55

joe

No, in the same way that the regulators would not give water a licence on the basis that it is safer than other drugs.

There is insufficient credible evidence to demonstrate that Lupuzor works. Until that changes, no prospect of being granted a licence.

[joeblogg2] 03/6/2019 11:19

Nobby thks for that but even so Lupuzor safety and less side effects to the other drugs not taken into consideration ??